Market Cap $111.1M
!


Corporate Spotlight
Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.
View the full Corporate Spotlight
PAR - close to a cure for osteoarthritis?
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PAR | DAY 112 - PART 2 | 06:21 | 1 | 164 | |||
|
|||||||
PAR | Questions for Investor Hub | 12/09/25 | 21 | 4.1K | |||
|
|||||||
PAR | Ann: Unmarketable Parcel Sale Facility | 12/09/25 | 43 | 6.4K | |||
|
|||||||
PAR | TGA study participation | 11/09/25 | 24 | 4.9K | |||
|
|||||||
PAR | DAY 112 | 11/09/25 | 8 | 2.0K | |||
|
|||||||
PAR | Ann: Evans and Partners Healthcare Conference Presentation | 11/09/25 | 11 | 2.6K | |||
|
|||||||
PAR | Share value | 10/09/25 | 40 | 8.4K | |||
|
|||||||
PAR | Ann: Application for quotation of securities - PAR | 10/09/25 | 12 | 2.1K | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |